<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>3(23)</volume><submitter>Nieborowska-Skorska M</submitter><funding>NCI NIH HHS</funding><journal>Blood advances</journal><pagination>4050-4054</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC6963253</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor.</pubmed_title><pmcid>PMC6963253</pmcid><funding_grant_id>P30 CA008748</funding_grant_id><funding_grant_id>U10 CA180820</funding_grant_id><funding_grant_id>R01 CA186238</funding_grant_id><funding_grant_id>U24 CA196172</funding_grant_id><pubmed_authors>Nieborowska-Skorska M</pubmed_authors><pubmed_authors>Paietta EM</pubmed_authors><pubmed_authors>Levine RL</pubmed_authors><pubmed_authors>Fernandez HF</pubmed_authors><pubmed_authors>Tallman MS</pubmed_authors><pubmed_authors>Skorski T</pubmed_authors><pubmed_authors>Litzow MR</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inhibition of the mutated c-KIT kinase in AML1-ETO-positive leukemia cells restores sensitivity to PARP inhibitor.</name><description/><dates><release>2019-01-01T00:00:00Z</release><publication>2019 Dec</publication><modification>2025-04-19T01:51:16.238Z</modification><creation>2025-04-07T12:23:58.623Z</creation></dates><accession>S-EPMC6963253</accession><cross_references><pubmed>31816060</pubmed><doi>10.1182/bloodadvances.2019000756</doi></cross_references></HashMap>